BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37647568)

  • 21. Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections.
    Barani M; Mukhtar M; Rahdar A; Sargazi G; Thysiadou A; Kyzas GZ
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA nanomaterials for preclinical imaging and drug delivery.
    Jiang D; England CG; Cai W
    J Control Release; 2016 Oct; 239():27-38. PubMed ID: 27527555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology platforms in diagnosis and treatment of primary brain tumors.
    Caruso G; Raudino G; Caffo M; Alafaci C; Granata F; Lucerna S; Salpietro FM; Tomasello F
    Recent Pat Nanotechnol; 2010 Jun; 4(2):119-24. PubMed ID: 20415658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma.
    Shabani L; Abbasi M; Amini M; Amani AM; Vaez A
    J Neurol Sci; 2022 Sep; 440():120316. PubMed ID: 35777316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and therapeutic uses of nanomaterials in the brain.
    Garbayo E; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Curr Med Chem; 2014; 21(36):4100-31. PubMed ID: 25139519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.
    Mitusova K; Peltek OO; Karpov TE; Muslimov AR; Zyuzin MV; Timin AS
    J Nanobiotechnology; 2022 Sep; 20(1):412. PubMed ID: 36109754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano-inspired smart medicines targeting brain cancer: diagnosis and treatment.
    Anand R; Kumar L; Mohan L; Bharadvaja N
    J Biol Inorg Chem; 2023 Feb; 28(1):1-15. PubMed ID: 36449063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
    Liu HL; Yang HW; Hua MY; Wei KC
    Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle technology for drug delivery across the blood-brain barrier.
    Lockman PR; Mumper RJ; Khan MA; Allen DD
    Drug Dev Ind Pharm; 2002 Jan; 28(1):1-13. PubMed ID: 11858519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomaterials for brain metastasis.
    Zhao Z; Chen Y; Sun T; Jiang C
    J Control Release; 2024 Jan; 365():833-847. PubMed ID: 38065414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for encephalic drug delivery using nanomaterials: The current status.
    V A; Cutinho LI; Mourya P; Maxwell A; Thomas G; Rajput BS
    Brain Res Bull; 2020 Feb; 155():184-190. PubMed ID: 31790722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could nanoparticle systems have a role in the treatment of cerebral gliomas?
    Caruso G; Caffo M; Alafaci C; Raudino G; Cafarella D; Lucerna S; Salpietro FM; Tomasello F
    Nanomedicine; 2011 Dec; 7(6):744-52. PubMed ID: 21419873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Nanomaterials in Neurodegenerative Diseases.
    Cui W; Fu W; Lin Y; Zhang T
    Curr Stem Cell Res Ther; 2021; 16(1):83-94. PubMed ID: 32213159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patented nanomedicines for the treatment of brain tumors.
    Caruso G; Raudino G; Caffo M
    Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.